Steven H. Wodka
I HAVE RETIRED.
On January 1, 2023, Steven H. Wodka retired from the practice of law.
On a pro bono basis, I will continue to serve in my court appointed positions as plaintiffs’ class counsel in the settled class actions of Gibbs, et al. v. DuPont, et al. v. The Goodyear Tire & Rubber Company, Civil Action No. 93-CV-0497C, United States District Court for the Western District of New York (hereinafter, “Gibbs”), and Artis, et al. v. Rohm and Haas Company, et al., Docket No. C-8-01, Superior Court of New Jersey, Chancery-Equity Division, Passaic County (hereinafter, “Artis”). Each case established a medical monitoring program for the class of exposed workers for the early detection of bladder cancer.
Eligibility for the Gibbs Class Action
You are a class member and are eligible for benefits if you are a retired or former employee of The Goodyear Tire & Rubber Company in Niagara Falls, New York, and were employed between January 1, 1957 and June 11, 1990 for more than 90 days in Department 245, in the Maintenance Department, as a janitor, in the Laboratory and Laboratory QC (Department 104), in the Yard (Department 191), and/or in Shipping (Department 121), were exposed to ortho-toluidine or aniline in the course of your job duties, and have not been diagnosed with bladder cancer.
Eligibility for the Artis Class Action
You are a class member and are eligible for benefits if you are a retired or former employee of Rohm and Haas, Morton International, and/or Patent Chemical in Paterson, New Jersey and were employed for more than 30 days between January 1, 1946 and December 31, 2000.
Exposure to ortho-toluidine and the risk of developing bladder cancer
Work at these plants in Niagara Falls, New York and Paterson, New Jersey created an excess risk of developing bladder cancer due to exposure to ortho-toluidine. The United States National Toxicology Program has classified ortho-toluidine as known to be a human carcinogen. The goal of these medical monitoring programs is to detect bladder cancer at the earliest possible date when treatment for bladder cancer is most successful.
If you are an eligible class member and have any questions, or any difficulty in participating in these programs, please contact:
Steven H. Wodka
577 Little Silver Point Road
Little Silver, New Jersey 07739
phone: (732) 530-2815